Allergy medicine brands in the United States:Which are most popular?
In September 2026, Benadryl was the most searched allergy medicine brand in the United States, accounting for 30.3% of all searches among the seven brands we track. When we checked with ChatGPT and Google AI Overviews, Flonase showed up in every answer. Allegra was recommended most often, coming first in three out of five responses.
BenadrylShare of searches 30.3%Mentioned in 2 of 5 AI answersPlace in AI recommendations 7th
ZyrtecShare of searches 24.7%Mentioned in 4 of 5 AI answersPlace in AI recommendations 3rd
FlonaseShare of searches 13.5%Mentioned in 5 of 5 AI answersPlace in AI recommendations 4th
ClaritinShare of searches 11.1%Mentioned in 4 of 5 AI answersPlace in AI recommendations 2nd
AllegraShare of searches 9.1%Mentioned in 4 of 5 AI answersPlace in AI recommendations 1st
Follow allergy medicine brands and get free monthly updates on what changed
By continuing you'll get index updates and occasional product news from Brandwave. Unsubscribe any time. Privacy
Top allergy medicine brands in ChatGPT and Google AI Overviews
In Brandwave's three ChatGPT questions and two Google AI Overviews, Flonase appeared every time. Allegra was recommended most often, coming first in three out of five answers. Claritin was second, and Zyrtec was third.
Most recommended by AI
Brands get a higher ranking if they are mentioned earlier in the answers.
Mentioned by AI
Each dot is one answer, filled in when that answer mentions the brand.
Flonase5 of 5Named in 3 of 3 ChatGPT answersNamed in 2 of 2 Google answers
Zyrtec4 of 5Named in 2 of 3 ChatGPT answersNamed in 2 of 2 Google answers
Claritin4 of 5Named in 2 of 3 ChatGPT answersNamed in 2 of 2 Google answers
Allegra4 of 5Named in 2 of 3 ChatGPT answersNamed in 2 of 2 Google answers
Nasacort3 of 5Named in 1 of 3 ChatGPT answersNamed in 2 of 2 Google answers
Benadryl2 of 5Named in 0 of 3 ChatGPT answersNamed in 2 of 2 Google answers
Xyzal2 of 5Named in 0 of 3 ChatGPT answersNamed in 2 of 2 Google answers
See every answer about allergy medicine brands
5 answers
Asked ChatGPT
“What's the best allergy medicine?”
Asked ChatGPT
“What's the best non-drowsy allergy medicine?”
Asked ChatGPT
“What's the best nasal spray for allergies?”
Searched Google, AI Overview
“allergy medicine”
Searched Google, AI Overview
“best allergy medicine”
Brands are shown in the order each answer named them. The survey took place in United States on October 27, 2026.
Which allergy medicine brands do people search for most?
This chart shows how often people search Google for each allergy medicine brand by name. Each line represents a brand's share of searches for all seven allergy medicine brands we track, month by month, from searches in United States.
Share of searches by month for Benadryl, Zyrtec, Flonase, Claritin, Allegra, Xyzal, Nasacort. The figures are in the table below the chart.
View monthly share of searches table
| Month | Benadryl | Zyrtec | Flonase | Claritin | Allegra | Xyzal | Nasacort |
|---|---|---|---|---|---|---|---|
| Oct 2025 | 32.3% | 21.6% | 14.4% | 11.8% | 7.9% | 9.7% | 2.4% |
| Nov 2025 | 30.8% | 25.2% | 13.8% | 11.3% | 7.6% | 9.2% | 2.3% |
| Dec 2025 | 29.7% | 24.3% | 16.2% | 10.9% | 7.3% | 8.9% | 2.7% |
| Jan 2026 | 33% | 22% | 18% | 9.9% | 6.6% | 8.1% | 2.4% |
| Feb 2026 | 28% | 22.9% | 18.7% | 12.6% | 6.9% | 8.4% | 2.5% |
| Mar 2026 | 24.2% | 24.2% | 16.2% | 13.2% | 8.9% | 10.8% | 2.7% |
| Apr 2026 | 22.6% | 27.6% | 15.1% | 12.4% | 10.1% | 10.1% | 2% |
| May 2026 | 26.3% | 26.3% | 14.4% | 11.8% | 9.6% | 9.6% | 1.9% |
| Jun 2026 | 33.3% | 22.2% | 12.2% | 12.2% | 8.1% | 10% | 2% |
| Jul 2026 | 34.7% | 23.2% | 12.7% | 10.4% | 8.5% | 8.5% | 2.1% |
| Aug 2026 | 32.3% | 26.4% | 11.8% | 11.8% | 7.9% | 7.9% | 1.9% |
| Sep 2026 | 30.3% | 24.7% | 13.5% | 11.1% | 9.1% | 9.1% | 2.2% |
| Rank | Brand | Share of searches | Estimated monthly branded searches | vs prior month | Share change |
|---|---|---|---|---|---|
| 1, held 1st | 30.3% | 450K | 0% | -2 points | |
| 2, held 2nd | 24.7% | 368K | 0% | -1.6 points | |
| 3, moved from 4th to 3rd | 13.5% | 201K | +21.8% | +1.7 pointsmoved from 4th to 3rd | |
| 4, moved from 3rd to 4th | 11.1% | 165K | 0% | -0.7 pointsmoved from 3rd to 4th | |
| 5, held 5th | 9.1% | 135K | +22.7% | +1.2 points | |
| 6, held 6th | 9.1% | 135K | +22.7% | +1.2 points | |
| 7, held 7th | 2.2% | 33.1K | +22.1% | +0.3 points |
1.
Benadryl30.3%
Held 1st. 450K estimated branded searches, 0% vs prior month. Share -2 points.
2.
Zyrtec24.7%
Held 2nd. 368K estimated branded searches, 0% vs prior month. Share -1.6 points.
3.
Flonase13.5%
Moved from 4th to 3rd. 201K estimated branded searches, +21.8% vs prior month. Share +1.7 points.
4.
Claritin11.1%
Moved from 3rd to 4th. 165K estimated branded searches, 0% vs prior month. Share -0.7 points.
5.
Allegra9.1%
Held 5th. 135K estimated branded searches, +22.7% vs prior month. Share +1.2 points.
6.
Xyzal9.1%
Held 6th. 135K estimated branded searches, +22.7% vs prior month. Share +1.2 points.
7.
Nasacort2.2%
Held 7th. 33.1K estimated branded searches, +22.1% vs prior month. Share +0.3 points.
Which brand is most popular in search among allergy medicine brands in the United States?
7 brands
In September 2026, Benadryl was the most searched among allergy medicine brands in the United States, with an estimated 450K branded searches, 30.3% of all searches for the seven we track. Zyrtec is in 2nd place, 5.5 percentage points behind at 24.7%.
| Brand | Share of searches | Peak | Low | Rank |
|---|---|---|---|---|
| 32.3% → 30.3% | 34.7%Jul 2026 | 22.6%Apr 2026 | 1st | |
| 21.6% → 24.7% | 27.6%Apr 2026 | 21.6%Oct 2025 | 2nd | |
| 14.4% → 13.5% | 18.7%Feb 2026 | 11.8%Aug 2026 | 3rd | |
| 11.8% → 11.1% | 13.2%Mar 2026 | 9.9%Jan 2026 | 4th | |
| 7.9% → 9.1% | 10.1%Apr 2026 | 6.6%Jan 2026 | 6th → 5th | |
| 9.7% → 9.1% | 10.8%Mar 2026 | 7.9%Aug 2026 | 5th → 6th | |
| 2.4% → 2.2% | 2.7%Dec 2025 | 1.9%May 2026 | 7th |
Each finding as a sentence
- Across the 12 months ending September 2026, Benadryl’s share of searches among allergy medicine brands in the United States decreased from 32.3% to 30.3%.
- Across the 12 months ending September 2026, Zyrtec’s share of searches among allergy medicine brands in the United States increased from 21.6% to 24.7%.
- Across the 12 months ending September 2026, Flonase’s share of searches among allergy medicine brands in the United States decreased from 14.4% to 13.5%.
- Across the 12 months ending September 2026, Claritin’s share of searches among allergy medicine brands in the United States decreased from 11.8% to 11.1%.
- Across the 12 months ending September 2026, Allegra’s share of searches among allergy medicine brands in the United States increased from 7.9% to 9.1%.
- Across the 12 months ending September 2026, Xyzal’s share of searches among allergy medicine brands in the United States decreased from 9.7% to 9.1%.
- Across the 12 months ending September 2026, Benadryl’s share of searches among allergy medicine brands in the United States peaked at 34.7% in July 2026 and was lowest at 22.6% in April 2026.
- Across the 12 months ending September 2026, Zyrtec’s share of searches among allergy medicine brands in the United States peaked at 27.6% in April 2026 and was lowest at 21.6% in October 2025.
- Across the 12 months ending September 2026, Flonase’s share of searches among allergy medicine brands in the United States peaked at 18.7% in February 2026 and was lowest at 11.8% in August 2026.
- Across the 12 months ending September 2026, Claritin’s share of searches among allergy medicine brands in the United States peaked at 13.2% in March 2026 and was lowest at 9.9% in January 2026.
- Across the 12 months ending September 2026, Allegra’s share of searches among allergy medicine brands in the United States peaked at 10.1% in April 2026 and was lowest at 6.6% in January 2026.
- Across the 12 months ending September 2026, Xyzal’s share of searches among allergy medicine brands in the United States peaked at 10.8% in March 2026 and was lowest at 7.9% in August 2026.
- Across the 12 months ending September 2026, Allegra rose from 6th to 5th among allergy medicine brands in the United States.
- Across the 12 months ending September 2026, Xyzal fell from 5th to 6th among allergy medicine brands in the United States.
- Across the 12 months ending September 2026, Nasacort held steady: its share of searches among allergy medicine brands in the United States moved less than 0.5 percentage points.
How did search popularity change for United States allergy medicine brands in September 2026?
6 changes

In September 2026, Flonase overtook Claritin to rank 3rd among allergy medicine brands in the United States, with 13.5% of the searches.

In September 2026, Allegra gained share of searches among allergy medicine brands in the United States, from 7.9% to 9.1%.

In September 2026, Xyzal gained share of searches among allergy medicine brands in the United States, from 7.9% to 9.1%.

In September 2026, Benadryl lost share of searches among allergy medicine brands in the United States, from 32.3% to 30.3%.

In September 2026, Zyrtec lost share of searches among allergy medicine brands in the United States, from 26.4% to 24.7%.

In September 2026, Claritin lost share of searches among allergy medicine brands in the United States, from 11.8% to 11.1%.
How are branded searches counted for allergy medicine brands?
7 search terms
Each brand's share of searches among allergy medicine brands comes from the terms listed under its name. When people mostly search for a brand because of something else it sells, only the searches that name this product count here.
Compare popularity between leading brands

Benadryl vs Zyrtec: compare popularity
Benadryl vs Flonase: compare popularity
Benadryl vs Claritin: compare popularity
Benadryl vs Allegra: compare popularity
Zyrtec vs Flonase: compare popularity
Zyrtec vs Claritin: compare popularity
Zyrtec vs Allegra: compare popularity
Flonase vs Claritin: compare popularity
Flonase vs Allegra: compare popularity
Claritin vs Allegra: compare popularity- Compare any of these brands

See your own brand in this picture
Brandwave tracks your branded demand next to your campaigns, spend and outcomes, so you can see what moved your numbers, not just that they moved.